Literature DB >> 2693875

Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation.

P Fernyhough1, J F Mill, J L Roberts, D N Ishii.   

Abstract

Neurotrophic factors may increase axon and dendrite growth in part by regulating the content of cytoskeletal elements such as microtubules, which are comprised of tubulin subunits. The mechanism by which insulin, insulin-like growth factors (IGFs), and nerve growth factor (NGF) can increase the relative abundance of tubulin mRNAs as a prelude to neurite formation was studied. Insulin significantly increased the abundance of tubulin mRNAs relative to total RNA in cultured human neuroblastoma SH-SY5Y cells. This increase was not the result of a generalized elevation of all transcripts, because tubulin mRNAs were elevated relative to poly(A)+ RNA as well. Moreover, whereas polymerases I and III were elevated in activity, polymerase II was not. Tubulin mRNAs were stabilized against degradation in the presence of actinomycin D by both insulin and IGF-I. In contrast, actin and histone 3.3 mRNAs were neither increased nor stabilized. Insulin did not alter alpha- or beta-tubulin gene transcription rates in nuclear run-off experiments, and did increase the relative synthesis of tubulin proteins. These results suggest that tubulin mRNA levels are increased mainly through selective stabilization by insulin and IGFs. Because NGF is known to stabilize tubulin mRNA levels also, stabilization of tubulin mRNAs is suggested to be a common event in the pathway leading to neurite elongation directed by neuritogenic polypeptides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693875     DOI: 10.1016/0169-328x(89)90044-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  22 in total

Review 1.  Molecular biology of the insulin-like growth factors. Relevance to nervous system function.

Authors:  J E Hepler; P K Lund
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

2.  In vivo peripheral nervous system insulin signaling.

Authors:  Caleb W Grote; Janelle M Ryals; Douglas E Wright
Journal:  J Peripher Nerv Syst       Date:  2013-09       Impact factor: 3.494

Review 3.  The yin-yang of dendrite morphology: unity of actin and microtubules.

Authors:  Penelope C Georges; Norell M Hadzimichalis; Eric S Sweet; Bonnie L Firestein
Journal:  Mol Neurobiol       Date:  2008-11-06       Impact factor: 5.590

4.  Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats.

Authors:  Mohamad-Reza Aghanoori; Darrell R Smith; Subir Roy Chowdhury; Mohammad Golam Sabbir; Nigel A Calcutt; Paul Fernyhough
Journal:  Exp Neurol       Date:  2017-08-10       Impact factor: 5.330

5.  Activation of the insulin-signaling pathway in sciatic nerve and hippocampus of type 1 diabetic rats.

Authors:  M R King; N J Anderson; C Liu; E Law; M Cundiff; T M Mixcoatl-Zecuatl; C G Jolivalt
Journal:  Neuroscience       Date:  2015-07-04       Impact factor: 3.590

6.  Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex.

Authors:  M M Niblock; J K Brunso-Bechtold; D R Riddle
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 7.  The role of the insulin-like growth factors in the central nervous system.

Authors:  A J D'Ercole; P Ye; A S Calikoglu; G Gutierrez-Ospina
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

8.  Chick embryo retina development in vitro: the effect of insulin.

Authors:  G Tesoriere; R Vento; V Morello; R M Tomasino; M Carabilló; M Lauricella
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

Review 9.  Corneal nerves in health and disease.

Authors:  Brittany Simmons Shaheen; May Bakir; Sandeep Jain
Journal:  Surv Ophthalmol       Date:  2014-01-23       Impact factor: 6.048

10.  Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.

Authors:  Predrag Serbedzija; James E Madl; Douglas N Ishii
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.